Picture of Avalo Therapeutics logo

AVTX — Avalo Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Brief: Avalo Therapeutics Inc Enters Into Sales Agreement With Oppenheimer & Co.

May 4 (Reuters) - Avalo Therapeutics Inc  AVTX.O :
    * AVALO THERAPEUTICS INC - ENTERED INTO SALES AGREEMENT WITH
OPPENHEIMER & CO.
    * AVALO: MAY OFFER, SELL, FROM TIME TO TIME THROUGH
OPPENHEIMER,
SHARES OF CO’S COMMON STOCK, PAR VALUE $0.001PER SHARE, HAVING
OFFERING PRICE OF UP TO $9MLN

Further company coverage:  AVTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Avalo Therapeutics

See all news